Many studies have been shown that fetal malformation and abnormal growth are significantly increased in pregnancies with poorly-controlled diabetes mellitus and that intensive glycaemic control is required in diabetic pregnancy. 1 Various indices including haemoglobin Ale, glycated protein and fructosamine are reported to be useful for assessing glycaemic control during pregnancy.t-' Glycated protein and fructosamine reflect glycaemic control levels over a shorter period, and so presumably more rapidly, than HbA1c" Measurement of glycated albumin seems more suitable than that of glycated protein because metabolism of serum albumin is better understood than that of other serum proteins. There are many reports of the usefulness of glycated albumin for assessing glycaemic control levels in non-pregnant diabetic patients. However, as there seem to be no reports on its value during pregnancy, we examined the changes of glycated albumin during pregnancy in comparison with those of other measurements.
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SUBJECTS AND METHOD
The subjects studied were 249 pregnant women with normal glucose tolerance before pregnancy. Their fasting plasma glucose, serum total protein (T'P), glycated albumin, fructosarnine, HbA le and urinary glucose concentrations were examined several times between week 10 and 37 of pregnancy. The women were classified into three groups: a normal group, 225 women showed neither glyco-Correspondence: Dr Kenji Shima.
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suria nor hyperglycaemia (fasting glucosẽ 6'1 mmollL) throughout pregnancy; glycosuria group, 13 women who showed glycosuria at least once but not hyperglycaemia; and a hyperglycaernia group, 11 women who showed a fasting glucose concentration of > 6· 1 mmollL at least once. Glycated albumin was measured by column affinity chromatography by the HPLC method described previously. 4 Fructosamine was measured by the nitroblue tetrazolium method with an assay kit from Hoffmann-La Roche Co. (Basle, Switzerland). HbA\c was measured by an HPLC method, and plasma glucose by the international standard method with glucose dehydrogenase. Serum total protein was measured by the biuret method. The coefficients of variation of these assays for glycated albumin, fructosamine, HbA le, plasma glucose and total protein were 3'6,1-7,2-6,2'3 and 0-6l1Jo, respectively. The mean glycated albumin in 153 non-pregnant women aged 18 to 30 (mean 20' 3, SD 2· 5 years) with normal glucose tolerance was 15'6, SD 0·6%.
For analysis, data were grouped into three gestational periods (weeks 10-19, 20-29, and 30-37 of gestation) named early, middle and late pregnancy, respectively. Data are given as means (SD). Statistical significance was analysed by ttest for paired and unpaired data or by analysis of variance.
RESULTS
The results are summarized in Table 1 . In normal pregnant women, fasting plasma glucose and glycated albumin did not change significantly as pregnancy progressed, total protein and fructosamine concentrations were significantly lower in middle and late pregnancy than in early pregnancy, and HbA 1e values increased significantly in late pregnancy. Thirteen of the pregnant women showed glycosuria at least once without hyper glycaemia. The fasting plasma glucose concentrations in this group were slightly, but not significantly, higher than those in the normal group. The glycated albumin and HbA l c values were significantly higher than those in the normal group in early pregnancy, but not in middle and late pregnancy. Total protein and fructosamine values tended to decrease in middle and late pregnancy, as in the normal group. They were not significantly different from those of the normal group throughout pregnancy.
In the hyperglycaemia group, the fasting plasma glucose and glycated albumin values were significantly increased in middle and late pregnancy, HbA lc was also increased in late pregnancy, but fructosamine was not significantly different from the normal group.
The glycated albumin values correlated significantly with those of fasting plasma glucose, fructosamine, fructosamine ratio to total protein and HbA 1C (r=0'15, 0'19, 0·21 and 0'17, respectively; all P< O' 002). Although the correlation coefficients were all very small, it is noted that glycated albumin correlated slightly but not significantly better with the fructosamine/ total protein ratio than with fructosamine. There was a significant correlation between fructosamine and total protein (r=0'33, P<O'OOI), but not between glycated albumin and total protein (r = O' 02, P = ns).
DISCUSSION
We found that in the normal group fasting plasma glucose and glycated albumin values did not change during pregnancy, whereas fructosamine was decreased in middle and late pregnancy. As reported by many others, fructosamine decreases with decrease of serum albumin concentration in advanced pregnancy. 3 Our results showed that total protein was decreased slightly, but significantly, in middle and late pregnancy, suggesting an apparent decrease in the fructosamine level. The fasting plasma glucose and glycated albumin values in the glycosuria group were slightly, but not significantly, higher than those in the normal group. In the glycosuria group fructosamine did not show a significant decrease in advanced pregnancy but tended to decrease with decrease of total protein. In the hyperglycaemia group, fasting plasma glucose and glycated albumin were significantlyincreased in middle and late pregnancy. The fructosamine concentrations in this group did not show any change as pregnancy progressed in spite of the significant increase in fasting plasma glucose. These data suggest that glycated albumin is not affected by change of the serum protein concentration and is a reliable index for assessing glycaemic levels during pregnancy. This idea is supported by the facts that there was a significant correlation between fructosamine and total protein, but not between glycated albumin and total protein, and that glycated albumin correlated slightly better with the fructosamine ratio to total protein than with fructosamine itself.
The increased HbA l c values in our hyperglycaemia group may be attributed to elevation of the glycaemic level, but it is not clear why the HbA l c level increased in late pregnancy in the normal group. Our glycated albumin values for normal subjects are higher than those reported previously, though reported values range widely from 1'5070 to 15% with one exceptional value of 27%. 5 Material in peak II in our chromatography, the glycated albumin fraction, is contaminated with about 10% of the non-glycated form judging from the glycated albumin values measured by radioimmunoassay for glycated protein. This is one of the reasons why our glycated albumin values for normal subjects are high, but the validity of the values measured by various methods has to be evaluated by measuring control samples.
